Sidoxia Capital Management »

Halozyme Therapeutics shares owned by Sidoxia Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sidoxia Capital Management from 13F filings

Historical chart of Sidoxia Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Sidoxia Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Sidoxia Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 35k 64.63

More positions owned by Sidoxia Capital Management

Sterling Construction Company (STRL)
Pacer Fds Tr Aristotle Pacifi (FLRT)
Alphabet Cap Stk Cl A (GOOGL)
Comfort Systems USA (FIX)
Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Parker-Hannifin Corporation (PH)
Invesco Exch Trd Slf Idx Buletshs 2027 (BSJR)
Apple (AAPL)
United Therapeutics Corporation (UTHR)
Cheniere Energy Com New (LNG)
Meta Platforms Cl A (META)
Halozyme Therapeutics (HALO)
Harmony Biosciences Hldgs In (HRMY)

View all positions for Sidoxia Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics